Skip to main content
. Author manuscript; available in PMC: 2020 May 1.
Published in final edited form as: Pharmacoepidemiol Drug Saf. 2019 Apr 3;28(5):740–753. doi: 10.1002/pds.4779

Figure 3.

Figure 3.

The proportion of regular opioid users, defined as 45+ days of use in each fixed 91-day quarter, during the quarters pre (0, −1, and −2) and post (quarters 1–20) incident breast cancer diagnosis. The red line denotes the number of breast cancer survivors at each quarter.

*Regular opioid use defined as having 45+ days of use in each 91-days quarter.Quarter #1 is the quarter in which the incident brest cancer was diagnosed.